MARKET

MRGR

MRGR

ProShares Merger
BATS

Real-time Quotes | Provided by Morningstar

40.77
-0.09
-0.23%
Opening 12:33 06/16 EDT
OPEN
40.77
PREV CLOSE
40.86
HIGH
40.77
LOW
40.77
VOLUME
265
TURNOVER
--
52 WEEK HIGH
41.09
52 WEEK LOW
37.44
TOTAL ASSET
42.87M
YTD YIELD
-0.36%
1D
5D
1M
3M
1Y
5Y
Global M&A activity fell to three-year low in 2020 as pandemic rattled markets
Global M&A activity rebounded in the back half of 2020 after dropping off a cliff in Q2, when companies contended with the financial market turmoil at the start of the
Seekingalpha · 12/31/2020 16:47
'Merger Monday' is back as economy continues to recover from COVID-19
A bout of dealmaking began over the weekend as AstraZeneca bulked up its rare disease portfolio with the $39B purchase of Alexion Pharmaceuticals (its biggest acquisition on record).Elsewhere in the
Seekingalpha · 12/14/2020 08:30
Stocks Gain on Stimulus Hopes in Choppy Trading: Markets Wrap
Bloomberg · 09/30/2020 21:27
Options on Treasury ETF Hint at Hedges for Higher U.S. Inflation
Bloomberg · 09/29/2020 11:21
No Data
Learn about the latest financial forecast of MRGR. Analyze the recent business situations of ProShares Merger through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-0.2563%
--
1-Week
-0.3672%
--
1-Month
-0.2641%
--
3-Month
1.4605%
--
6-Month
-1.2051%
--
YTD
-0.3636%
--
1-Year
1.9365%
--
3-Year
2.8120%
--
5-Year
1.4908%
--
Since Inception
0.2598%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
ProShares Merger
Risk
Medium-low risk
Inception Date
2012-12-11
Benchmark
S&P Real Assets TR USD
Advisor Company
ProShares
Custodian
JPMorgan
Manager
Ilyasov/Hanson